Abstract
Guillain-Barré syndrome (GBS) is the most common cause of acute paralysis and neuromuscular ventilatory failure. Although treatment with plasma exchange and immune globulins has decreased the duration of mechanical ventilation by half, 10% to 30% of patients require mechanical ventilation, 5% to 10% remain seriously disabled, and 3% to 8% die as a result of largely avoidable complications. Good clinical outcome depends to a large extent on the anticipation and management of ventilatory failure and its complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
